title: Reply to 'complementary data for long-term infliximab use in psoriasis'.
authors.affiliation: Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.
authors.forename: Adam J
authors.initials: AJ
authors.lastname: Luber
authors.affiliation: Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.
authors.forename: Cindy L
authors.initials: CL
authors.lastname: Tsui
authors.affiliation: Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.
authors.forename: Gillian M
authors.initials: GM
authors.lastname: Heinecke
authors.affiliation: Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.
authors.forename: Mark G
authors.initials: MG
authors.lastname: Lebwohl
authors.affiliation: Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: Jacob.levittmd@gmail.com.
authors.forename: Jacob O
authors.initials: JO
authors.lastname: Levitt
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D003879:Dermatologic Agents / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D011565:Psoriasis / Q000175:diagnosis* / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents